TITLE

Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS

AUTHOR(S)
Vrtačnik-Bokal, Eda; Klun, Irma Virant; Verdenik, Ivan
PUB. DATE
January 2009
SOURCE
Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jan2009, Vol. 18 Issue 1, p21
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The aim of this study was to determine whether follicular oestradiol and vascular endothelial growth factor (VEGF) concentrations in women with polycystic ovarian syndrome (PCOS) differ according to the use of gonadotrophin-releasing hormone (GnRH) antagonists or GnRH agonists. Furthermore, the effect of follicular oestradiol and VEGF concentrations on oocyte and embryo quality was investigated. In this prospective clinical study, 20 women with PCOS undergoing intracytoplasmic sperm injection for male factor infertility were included using a GnRH antagonist or a GnRH agonist protocol. In each follicle, oestradiol and VEGF concentrations were determined. In the GnRH antagonist group 254 follicles and in the GnRH agonist group 245 follicles, were aspirated. Fewer metaphase II (MII) and more immature and degenerative oocytes were registered in the GnRH antagonist group. Follicular oestradiol and VEGF were lower in the GnRH antagonist group (P = 0.014 and P < 0.001, respectively). Moreover, higher oestradiol concentrations were related to embryos of higher quality (P = 0.037). It is concluded that GnRH antagonists decrease follicular oestradiol and VEGF concentrations and the number of retrieved MII oocytes in women with PCOS.
ACCESSION #
42834576

 

Related Articles

  • Ovarian stimulation in women with high and low body mass index: GnRH agonist versus GnRH antagonist. Kumbak, Banu; Akbas, Hande; Sahin, Levent; Karlikaya, Guvenc; Karagozoglu, Hale; Kahraman, Semra // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Mar2010, Vol. 20 Issue 3, p314 

    This study evaluated women with a high body mass index (BMI) (>40 kg/m²) and low BMI (<18 kg/m²) undergoing assisted reproduction treatment and determined whether the type of gonadotrophin-releasing hormone (GnRH) analogue used has an impact on cycle parameters and outcome. The study...

  • Comparing GnRH agonist long protocol and gnrh antagonist protocol in outcome the first cycle of ART. Firouzabadi, Razieh; Ahmadi, Shahnaz; Oskouian, Homa; Davar, Robab // Archives of Gynecology & Obstetrics;Jan2010, Vol. 281 Issue 1, p81 

    This prospective study evaluated the efficacy of gonadotropin-releasing hormone (GnRH) antagonist protocol in comparison with the GnRH agonist protocol in the first cycle of assisted reproductive technique (ART). We randomized 235 patients undergoing ART for the first time. The first group was...

  • Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index. Orvieto, Raoul; Nahum, Ravit; Meltcer, Simion; Homburg, Roy; Rabinson, Jacob; Anteby, Eyal Y.; Ashkenazi, Jacob // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Mar2009, Vol. 18 Issue 3, p333 

    In an attempt to examine whether body mass index (BMI) may influence IVF outcome in polycystic ovary syndrome (PCOS) patients undergoing ovarian stimulation with either gonadotrophin-releasing hormone (GnRH)-agonist (agonist group) or antagonist (antagonist group), 100 IVF cycles were studied:...

  • Comparison of GnRH agonists and antagonists in the outcome of IVF/ICSI in women with polycystic ovary syndrome. Zeinalzadeh, M.; Norani, N.; Esmaeilzadeh, S.; Yousefniapasha, Y.; Firoozpour, M.; Khafri, S. // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p58 

    Introduction: To compare the outcome of using gonadotropin-releasing hormone (GnRH) antagonists versus agonists in women with polycystic ovary syndrome (PCOS) who underwent controlled ovarian hyper stimulation (COH) for assisted reproductive techniques (ART). Materials and Methods: A total of...

  • GnRH Antagonist Produces Similar Results as GnRH-Agonist.  // Fertility Weekly;12/6/2010, p8 

    The article presents a study which aims to determine the effectiveness of luteinizing hormone releasing hormone (GnRH) antagonist and luteinizing hormone releasing hormone (GnRH) agonist protocol in polycystic ovary syndrome (PCOS) patients pretreated with oral contraceptive pill (OCP)....

  • ART, clinical: GnRH agonist/antagonist.  // Human Reproduction;Jul2007 Supplement 1, Vol. 22, pi120 

    The article presents abstracts on the use of gonadotropin-releasing hormone (GnRH) agonists and antagonists in assisted reproductive technology (ART), including the administration of gonadoliberine analogues (GnRH-a) to patients with Hodgkin lymphoma (HL) during chemotherapy and prevention of...

  • Duration of Stimulation is Shorter with GnRH Antagonist for Poor Responders.  // Fertility Weekly;2/20/2012, p8 

    The article reports on the study conducted by D. Pu and colleagues which evaluates the efficacy of luteinizing hormone releasing hormone antagonist (GnRH-ant) versus GnRh agonist (GnRH-a) protocols for ovarian stimulation in poor responders of in vitro fertilization (IVF). The researchers...

  • Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial. D. Bodri; V. Vernaeve; J.J. Guillén; R. Vidal; F. Figueras; O. Coll // Human Reproduction;Sep2006, Vol. 21 Issue 9, p2246 

    BACKGROUND: Little information is available on the outcome of controlled ovarian hyperstimulation (COH) using GnRH antagonist in oocyte donation cycles especially in comparison with the short GnRH agonist protocol. This study was aimed at comparing the two stimulation protocols in oocyte...

  • The role of GnRH antagonists in assisted reproduction. Barri, Pedro N.; Martinez, Francisca; Coroleu, Buenaventura; Tur, Rosa // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p14 

    The different schemes of application of gonadotrophin-releasing hormone (GnRH) antagonists in ovarian stimulation protocols for assisted reproduction are reviewed. Starting from the initial schemes of single and/or multiple doses, the efficacy of GnRH antagonists in 'soft' protocols of ovarian...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics